Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Carterra nets $6M in funding
March 2020
SHARING OPTIONS:

SALT LAKE CITY—Earlier this quarter, Carterra Inc. announced the closing of a $6-million round of financing led by Ballast Point Ventures, with participation from its current investor Telegraph Hill Partners. Carterra intends to use the funds to boost the continued adoption of its Carterra LSA high-throughput Surface Plasmon Resonance (HT-SPR) antibody screening platform, as well as the development of new products and applications. Carterra LSA enables high information content assays earlier in development—during antibody screening—and can measure binding kinetics and affinities of hundreds of interactions in parallel, performing epitope binning experiments on up to 384 antibodies simultaneously.
 
“Carterra’s proprietary technology addresses a key objective of the pharmaceutical industry by helping to minimize the time it takes to develop new therapeutics,” said Matt Rice, partner at Ballast Point Ventures. “We’re excited to provide resources and guidance as Carterra continues its growth.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
478 Bay Street, Suite A213
Midland, Ontario, Canada L4R 1K9
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.